Newsfeeds - Spark Newswire

2 minute read

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More

Today, 2:33 PM

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.

ABT

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 2:33 PM

Gainers

ASLN

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 2:33 PM

Gainers

BFRI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 2:33 PM

Gainers

AGLE

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 2:33 PM

Gainers

AGRX

13 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 2:33 PM

During Friday's morning session, 234 stocks hit new 52-week lows.

ACIW

1 minute read

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

By Vandana Singh

Today, 2:33 PM

Kaleido Biosciences Inc (NASDAQ:KLDO) has delivered formal notice to voluntarily delist its common stock from NASDAQ as the Company will…

KLDO

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For April 4, 2022

By Benzinga Insights

Today, 2:33 PM

Upgrades

ALHC

1 minute read

Chardan Capital Downgrades Kaleido Biosciences to Neutral, Lowers Price Target to $1.7

By Benzinga Newsdesk

Today, 2:33 PM

Chardan Capital analyst Keay Nakae downgrades Kaleido Biosciences (NASDAQ:KLDO) from Buy to Neutral and lowers the price target from $3 to $1.7.

KLDO

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 2:33 PM

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

ABEO